Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS hosts first International Congress on Calvin Research in Africa
2010-08-31

Present at the Calvin Research Conference were, from the left: Dr Frank Ewerszumrode (OP), Faculty of Catholic Theology at the University of Mainz in Mainz, Germany; Prof. Dr Herman Selderhuis, President of the International Congress on Calvin Research; Prof. Dolf Britz, Director of the Jonathan Edwards Centre Africa at the UFS; and Ntabanyane Tseuoa, Masters student in the Jonathan Edwards Centre at the UFS.
Photo: Leonie Bolleurs

The first International Congress on Calvin Research in Africa was this week presented on the Main Campus of the University of the Free State (UFS) in Bloemfontein. This was the tenth Calvin Research Conference presented. The conference is presented every four years.

The theme of the congress was: Reconciliation in the Theology of Calvin. Presentations were made about, amongst others, Calvin’s viewpoint regarding slavery and social justice. There was also a discussion about the extraordinary interest to record the original Calvin texts in databases and to make it available to researchers worldwide.

According to Prof. Dolf Britz, Director of the Jonathan Edwards Centre at the UFS, the objective of the congress was to study original Calvin sources critically. “An important part of the congress’ work is to publish an important part of Calvin’s work in a comprehensive text critical edition. This process is already well advanced and includes a number of unknown texts,” said Prof. Britz.

With its research on Calvin, the UFS emphasises the study of original theological sources. “This approach makes the Faculty of Theology part of the UFS’s strategy towards internationalisation. This is also one of the reasons why the UFS was selected by Yale University in America as partner in the recent establishment of the Jonathan Edwards Centre Africa,” said Prof. Britz, whose brainchild it was to also include young upcoming researchers with the study of original sources and classical languages such as Latin.

The congress was attended by researchers and academics from across the world. Twenty young, emerging researchers formed part of this group that was invited by the UFS. According to Prof. Britz, these young researchers are the top achievers at their respective universities, such as the North-West University, Stellenbosch University, Mukanyo Theological College in the Pretoria area and the UFS.

At this event, attended by more than 70 world-renowned Calvin scholars from countries like, amongst others, Taiwan, Japan, South Korea, Finland, Switzerland, France, The Netherlands, America, Germany and Hungary; UFS academics like Prof. Eric de Boer, Extraordinary Professor in Classical and Reformed Theology and students like Rev. Ntabanyane Tseuoa from Lesotho, read and presented papers as well.

According to Prof. Britz this congress was a very good opportunity to introduce the UFS to the rest of the world.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
31 August 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept